EFOMP - 2nd Symposium on Molecular Radiotherapy Dosimetry: The Future of Theragnostics (SMRD2)

Publication Date: Mar 8th, 2025 23:08, Category: EFOMP Announcements

After the success of the first edition, the EFOMP Special Interest Group for Radionuclide Internal Dosimetry and the Hellenic Association of Medical Physicists will organise the second Symposium on Molecular Radiotherapy Dosimetry in Athens, Greece, in November 2025 following the success of the first Symposium on Molecular Rdaiotherapy Dosimetry.

The objective of the EFOMP Special Interest Group (SIG) for Radionuclide Internal Dosimetry (SIG_FRID) is to establish a network of medical physicists working in radionuclide dosimetry. The SIG aims to fulfil the need for networking, education, research and professional exchanges in this field. To fulfil these aims, EFOMP SIG_FRID will organise a Symposium on molecular radiotherapy dosimetry in Athens, Greece.

The Symposium aims:

To review and discuss ongoing developments in radionuclide internal dosimetry at a time of rapid expansion of theragnostics and molecular radiotherapy, and to consider the way ahead with informed treatments for patients’ benefit.